for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Fulgent Genetics Inc

FLGT.OQ

Latest Trade

91.71USD

Change

5.62(+6.53%)

Volume

402,943

Today's Range

85.63

 - 

91.84

52 Week Range

30.06

 - 

189.81

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
86.09
Open
87.12
Volume
402,943
3M AVG Volume
14.69
Today's High
91.84
Today's Low
85.63
52 Week High
189.81
52 Week Low
30.06
Shares Out (MIL)
29.52
Market Cap (MIL)
2,707.40
Forward P/E
8.13
Dividend (Yield %)
--

Next Event

Q3 2021 Fulgent Genetics Inc Earnings Release

Latest Developments

More

Fulgent Genetics Posts Q2 EPS Of $2.59

Fulgent Genetics Announces Incremental Strategic Investment In Chinese Joint Venture, Ff Gene Biotech

Xilong Scientific's Unit Sells Stake In Biological Firm To Fulgent Investment Development

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Fulgent Genetics Inc

Fulgent Genetics, Inc. is a technology company. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. The Company has developed a technology platform that integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory processes. The Company's technology platform performs full-gene sequencing with deletion/duplication analysis in single-gene tests; pre-established, multi-gene, disease-specific panels; and customized panels that can be tailored to meet specific customer needs. The Company's product Picture Genetics, a new line of at-home screening tests that combines the company’s advanced Next generation sequencing (NGS) solutions with actionable results and genetic counseling options for individuals.

Industry

Medical Equipment & Supplies

Contact Info

4978 Santa Anita Ave Ste 205

TEMPLE CITY, CA

91780-3600

United States

+1.626.3500537

https://www.fulgentgenetics.com/

Executive Leadership

Ming Hsieh

Chairman of the Board, President, Chief Executive Officer

Paul Kim

Chief Financial Officer

Jian Xie

Chief Operating Officer

Han Lin Gao

Chief Scientific Officer, Laboratory Director

John Bolger

Independent Director

Key Stats

2.67 mean rating - 3 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

0.0K

2019

0.0K

2020

0.4K

2021(E)

0.8K
EPS (USD)

2018

-0.090

2019

0.190

2020

9.100

2021(E)

12.251
Price To Earnings (TTM)
5.30
Price To Sales (TTM)
2.98
Price To Book (MRQ)
2.97
Price To Cash Flow (TTM)
5.46
Total Debt To Equity (MRQ)
2.30
LT Debt To Equity (MRQ)
0.65
Return on Investment (TTM)
96.97
Return on Equity (TTM)
85.46

Latest News

Latest News

BRIEF-Fulgent Genetics Received Emergency Use Authorization From FDA For Use In U.S.

* FULGENT GENETICS ANNOUNCES FDA AUTHORIZATION AND LAUNCH OF AT-HOME TESTING SERVICE FOR COVID-19

BRIEF-Fulgent Genetics Receives Emergency Use Authorization From The FDA For Its RT-PCR Test For Detection Of SARS-CoV-2

* FULGENT GENETICS RECEIVES EMERGENCY USE AUTHORIZATION FROM THE FDA FOR ITS RT-PCR TEST FOR DETECTION OF SARS-COV-2, THE VIRUS THAT CAUSES COVID-19

BRIEF-Fulgent Genetics Q1 Revenue Rose 44% To $7.8 Million

* FULGENT GENETICS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS

BRIEF-Fulgent Genetics Provides Update On Testing For COVID-19

* FULGENT GENETICS INC - HAS SUBMITTED SEVERAL COVID-19 TESTS TO US FOOD AND DRUG ADMINISTRATION (FDA) FOR EMERGENCY USE AUTHORIZATION (EUA) IN US

BRIEF-Fulgent Genetics Announces Launch Of Next Generation Sequencing Test To Detect Coronavirus Disease

* FULGENT GENETICS ANNOUNCES LAUNCH OF NEXT GENERATION SEQUENCING (NGS) TEST TO DETECT CORONAVIRUS DISEASE (COVID-19)

BRIEF-Fulgent Genetics Reports Q4 Loss Per Share $0.01

* FULGENT GENETICS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up